药物对比
Tolbutamide vs Insulin Icodec
Tolbutamide与Insulin Icodec：刺激胰岛素分泌的口服第一代磺脲类与用于2型糖尿病血糖控制的每周一次基础胰岛素类似物（Awiqli）。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes considering oral sulfonylureas versus once-weekly insulin therapy may compare Tolbutamide and Insulin Icodec.
结论
Both Tolbutamide and Insulin Icodec treat type 2 diabetes but are not interchangeable due to distinct mechanisms and dosing.
全部药物对比